Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Alveolar type II epithelial cell FASN maintains lipid homeostasis in experimental COPD
Li-Chao Fan, … , Jin-Fu Xu, Suzanne M. Cloonan
Li-Chao Fan, … , Jin-Fu Xu, Suzanne M. Cloonan
Published August 22, 2023
Citation Information: JCI Insight. 2023;8(16):e163403. https://doi.org/10.1172/jci.insight.163403.
View: Text | PDF
Research Article Metabolism Pulmonology

Alveolar type II epithelial cell FASN maintains lipid homeostasis in experimental COPD

  • Text
  • PDF
Abstract

Alveolar epithelial type II (AEC2) cells strictly regulate lipid metabolism to maintain surfactant synthesis. Loss of AEC2 cell function and surfactant production are implicated in the pathogenesis of the smoking-related lung disease chronic obstructive pulmonary disease (COPD). Whether smoking alters lipid synthesis in AEC2 cells and whether altering lipid metabolism in AEC2 cells contributes to COPD development are unclear. In this study, high-throughput lipidomic analysis revealed increased lipid biosynthesis in AEC2 cells isolated from mice chronically exposed to cigarette smoke (CS). Mice with a targeted deletion of the de novo lipogenesis enzyme, fatty acid synthase (FASN), in AEC2 cells (FasniΔAEC2) exposed to CS exhibited higher bronchoalveolar lavage fluid (BALF) neutrophils, higher BALF protein, and more severe airspace enlargement. FasniΔAEC2 mice exposed to CS had lower levels of key surfactant phospholipids but higher levels of BALF ether phospholipids, sphingomyelins, and polyunsaturated fatty acid–containing phospholipids, as well as increased BALF surface tension. FasniΔAEC2 mice exposed to CS also had higher levels of protective ferroptosis markers in the lung. These data suggest that AEC2 cell FASN modulates the response of the lung to smoke by regulating the composition of the surfactant phospholipidome.

Authors

Li-Chao Fan, Keith McConn, Maria Plataki, Sarah Kenny, Niamh C. Williams, Kihwan Kim, Jennifer A. Quirke, Yan Chen, Maor Sauler, Matthias E. Möbius, Kuei-Pin Chung, Estela Area Gomez, Augustine M.K. Choi, Jin-Fu Xu, Suzanne M. Cloonan

×

Figure 3

Generation of FasniΔAEC2 mice with altered lung lipid levels.

Options: View larger image (or click on image) Download as PowerPoint
Generation of FasniΔAEC2 mice with altered lung lipid levels.
(A) Fasnfl...
(A) Fasnfl/fl and Sftpc-Cre+/+ mice were crossed to generate FasniΔAEC2 and control SftpcCreERT2+/– mice, and both were induced by tamoxifen to drive CreERT2. (B) Representative IHC staining of FASN in lung tissue from FasniΔAEC2 and control SftpcCreERT2+/– mice (n = 4 per group). Scale bars, 100 μm, (n = 3 experiments). (C and D) Representative immunoblot (n = 3 experiments) (C) with quantification (D) of FASN, ACLY, and ACC protein expression in primary isolated AEC2 cells and whole lung homogenates from FasniΔAEC2 and control SftpcCreERT2+/– mice (n = 3 per group). **P < 0.01 by Student’s unpaired t test. Immunoblotting for FASN, ACLY, and β-actin was carried out on the same membrane; immunoblotting for ACC was carried out on a separate membrane. The same samples were used to load both gels. (E–G) Lipidomic profiling (E) of whole lung lipid extracts from FasniΔAEC2 and control SftpcCreERT2+/– mice with subgroup analysis of (F) acyl carnitine (AC) and (G) phosphatidylglycerol (PG) species. Red dots denote P < 0.05 fold-change of +2; blue dots denote P < 0.05 fold-change of –2. Data are expressed as mean ± SEM. (*P < 0.05, **P < 0.01, by Student’s unpaired t test, n = 3 mice per group of 1 independent experiment.) (H) Gene ontology pathway analysis of lipid metabolic processes of significantly altered genes represented as a (I) heatmap from whole lung transcriptomic profiling of FasniΔAEC2 and control SftpcCreERT2+/– mice (n = 3 mice per group, 1 independent experiment).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts